Latest Updates of Viva's Portfolio Companies
/PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term...
Source: prnewswire.com
Stay updated with breaking news from Detlev Biniszkiewicz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
The firm is studying its KIR3DL3-targeted monoclonal antibody NPX267 in patients with metastatic solid tumors and conducting exploratory biomarker analysis.